National Institutes of Health Center for Scientific Review; Notice of Closed Meetings, 42583-42584 [E8-16510]
Download as PDF
<![CDATA[
42583
Federal Register / Vol. 73, No. 141 / Tuesday, July 22, 2008 / Notices
REPORTING REQUIREMENTS
Number of
respondents
Regulatory/section requirements
Responses
per respondent
Total annual
responses
Hours per
response
Total hour
burden
HPSL Program:
57.206(a)(2), Student Financial Aid Transcript ............
57.208(c), Loan Information Disclosure .......................
57.210(b)(1)(i), Entrance Interview ...............................
57.210(b)(1)(ii), Exit Interview ......................................
57.210(b)(1)(iii), Notification of Repayment ..................
57.210(b)(1)(iv), Notification During Deferment ...........
57.210(b)(1)(vi), Notification of Delinquent Accounts ...
57.210(b)(1)(x), Credit Bureau Notification ..................
57.210(b)(4)(i), Write-off of Uncollectible Loans ..........
57.211(a) Disability Cancellation ..................................
57.215(a)(2), Administrative Hearings ..........................
57.215(a)(d), Administrative Hearings ..........................
4,600
435
435
*477
*477
*477
*477
*477
20
10
0
0
1
68.73
68.73
12
30.83
24.32
10.28
8.03
1.00
1
0
0
4,600
29,898
29,898
5,724
14,706
11,601
4,904
3,830
20
10
0
0
.25
.0833
0.167
0.5
0.167
0.0833
0.167
0.6
3.0
.75
0
0
1,150
2,490
4,993
2,862
2,456
966
819
2,298
60
8
0
0
HPSL Subtotal .......................................................
7,885
........................
105,190
........................
18,102
NSL Program:
57.306(a)(2), Student Financial Aid Transcript ............
57.310(b)(1)(i), Entrance Interview ...............................
57.310(b)(1)(ii), Exit Interview ......................................
57.310(b)(1)(iii), Notification of Repayment ..................
57.310(b)(1)(iv), Notification During Deferment ...........
57.310(b)(1)(vi), Notification of Delinquent Accounts ...
57.310(b)(1)(x), Credit Bureau Notification ..................
57.310(b)(4)(i), Write-off of Uncollectible Loans ..........
57.311(a), Disability Cancellation .................................
57.315(a)(1)(ii), Administrative Hearings ......................
57.316(a)(d), Administrative Hearings ..........................
4,100
304
*486
*486
*486
*486
*486
20
10
0
0
1
23.51
3.77
6.18
0.65
4.61
8.3
1.0
1.0
0
0
4,100
7,147
1,832
3,003
316
2,240
4,003
20
10
0
0
0.25
0.167
0.5
0.167
0.083
0.167
0.6
3.5
0.8
0
0
1,025
1,193
916
501
26
374
2,420
70
8
0
0
NSL Subtotal .........................................................
6,864
........................
22,703
........................
6,535
* Includes active and closing schools.
E-mail comments to
paperwork@hrsa.gov or mail to: HRSA
Reports Clearance Officer, Room 10–33,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: July 16, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E8–16780 Filed 7–21–08; 8:45 am]
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, DNA
Replication, Repair and Transcription.
Date: July 29, 2008.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: David J. Remondini, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892, 301–435–
1038, remondid@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, Urology
Applications.
Date: August 4, 2008.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on PROD1PC70 with NOTICES
National Institutes of Health Center for
Scientific Review; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
VerDate Aug<31>2005
19:47 Jul 21, 2008
Jkt 214001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ryan G. Morris, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, Membrane
Channels, Neuroimmunology, and Gene
Expression.
Date: August 5–8, 2008.
Time: 2 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Joanne T. Fujii, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4184,
MSC 7850, Bethesda, MD 20892, (301) 435–
1178, fujiij@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, Special
Reviews in Bioengineering.
E:\FR\FM\22JYN1.SGM
22JYN1
42584
Federal Register / Vol. 73, No. 141 / Tuesday, July 22, 2008 / Notices
Date: August 8, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: George W. Chacko, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7849, Bethesda, MD 20892, 301–435–
1245, chackoge@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Eye Institute,
Special Emphasis Panel, Clinical Grant
Applications.
Date: August 4, 2008.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Houmam H Araj, PhD.,
Scientific Review Administrator, Division of
Extramural Research, National Eye Institute,
NIH 5635 Fishers Lane, Suite 1300, Bethesda,
MD 20892–9602, 301–451–2020,
ha50c@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: July 14, 2008.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–16510 Filed 7–21–08; 8:45 am]
Dated: July 14, 2008.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–16511 Filed 7–21–08; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Substance Abuse and Mental Health
Services Administration
National Eye Institute; Notice of Closed
Meetings
sroberts on PROD1PC70 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute,
Special Emphasis Panel, NEI Institutional
Training Grant Applications.
Date: July 30, 2008.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Anne E. Schaffner, PhD,
Scientific Review Administrator, Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
VerDate Aug<31>2005
19:47 Jul 21, 2008
Jkt 214001
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Proposed Project: Access to Recovery
(ATR) Program Cross-Site Evaluation—
New
SAMHSA’s Center for Substance
Abuse Treatment (CSAT) is conducting
a cross-site evaluation of the Access to
Recovery (ATR) program. CSAT’s ATR
program is a competitive, discretionary
grant awarded to 18 States, the District
of Columbia, and five Tribal
Organizations to develop and operate a
voucher-based substance abuse
treatment financing system. The
primary focus of the ATR program is to
improve access by utilizing treatment
payment vouchers, to expand
independent client choice of treatment
providers, to expand access to both
clinical treatment and recovery support
services (RSS), and to increase
substance abuse treatment capacity by
increasing the array of faith-based and
community organizations through
which clinical treatment and RSS can be
offered. The purpose of the cross-site
evaluation is to examine how grantees
implement the ATR program and the
program’s impact on existing treatment
systems and client outcomes and to
inform future policy on the
development and implementation of
substance abuse treatment voucher
systems.
Two surveys will be administered as
part of this evaluation. One survey will
be administered to a sample of clients
participating in the ATR program and a
second survey will be administered to
service organizations participating in a
grantee’s ATR program. The client
survey will be administered following
the 6-month post-intake Government
Performance and Results Act (GPRA)
follow-up (OMB No. 0930–0208), using
the same data collection methods as the
GPRA data collection to reduce client
burden. GPRA data collection methods
vary by ATR grantee; typically, grantees
collect GPRA data in-person, but in
special cases they may use a telephone
interview. The ATR client survey
includes questions on client choice,
ease of obtaining services through an
ATR program, and client satisfaction.
The provider survey will be
administered through a Web survey
instrument and will target a key
informant in the organization to
complete the survey. Providers unable
to access or complete the Web survey
will be provided with a paper version of
the survey. The provider survey
includes questions on organizational
characteristics, satisfaction with the
ATR program, and experience
participating in the ATR program.
E:\FR\FM\22JYN1.SGM
22JYN1
]]>Agencies
[Federal Register Volume 73, Number 141 (Tuesday, July 22, 2008)]
[Notices]
[Pages 42583-42584]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-16510]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Center for Scientific Review;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, DNA Replication, Repair and Transcription.
Date: July 29, 2008.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: David J. Remondini, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210, MSC 7890, Bethesda, MD
20892, 301-435-1038, remondid@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, Urology Applications.
Date: August 4, 2008.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ryan G. Morris, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301-435-
1501, morrisr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, Membrane Channels, Neuroimmunology, and Gene
Expression.
Date: August 5-8, 2008.
Time: 2 p.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Joanne T. Fujii, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 20892, (301) 435-
1178, fujiij@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review, Special
Emphasis Panel, Special Reviews in Bioengineering.
[[Page 42584]]
Date: August 8, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: George W. Chacko, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170, MSC 7849, Bethesda, MD
20892, 301-435-1245, chackoge@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: July 14, 2008.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-16510 Filed 7-21-08; 8:45 am]
BILLING CODE 4140-01-M
